These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16101349)

  • 1. Elicitation of immunity in mice after immunization with the S2 subunit of the severe acute respiratory syndrome coronavirus.
    Guo Y; Sun S; Wang K; Zhang S; Zhu W; Chen Z
    DNA Cell Biol; 2005 Aug; 24(8):510-5. PubMed ID: 16101349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus.
    Woo PC; Lau SK; Tsoi HW; Chen ZW; Wong BH; Zhang L; Chan JK; Wong LP; He W; Ma C; Chan KH; Ho DD; Yuen KY
    Vaccine; 2005 Oct; 23(42):4959-68. PubMed ID: 15993989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope mapping and biological function analysis of antibodies produced by immunization of mice with an inactivated Chinese isolate of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).
    Chou TH; Wang S; Sakhatskyy PV; Mboudjeka I; Lawrence JM; Huang S; Coley S; Yang B; Li J; Zhu Q; Lu S
    Virology; 2005 Mar; 334(1):134-43. PubMed ID: 15749129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies.
    He Y; Lu H; Siddiqui P; Zhou Y; Jiang S
    J Immunol; 2005 Apr; 174(8):4908-15. PubMed ID: 15814718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs.
    Sekimukai H; Iwata-Yoshikawa N; Fukushi S; Tani H; Kataoka M; Suzuki T; Hasegawa H; Niikura K; Arai K; Nagata N
    Microbiol Immunol; 2020 Jan; 64(1):33-51. PubMed ID: 31692019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of humoral responses in mice immunized with plasmid DNAs encoding SARS-CoV spike gene fragments.
    Zeng F; Chow KY; Hon CC; Law KM; Yip CW; Chan KH; Peiris JS; Leung FC
    Biochem Biophys Res Commun; 2004 Mar; 315(4):1134-9. PubMed ID: 14985131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of specific immune responses by severe acute respiratory syndrome coronavirus spike DNA vaccine with or without interleukin-2 immunization using different vaccination routes in mice.
    Hu H; Lu X; Tao L; Bai B; Zhang Z; Chen Y; Zheng F; Chen J; Chen Z; Wang H
    Clin Vaccine Immunol; 2007 Jul; 14(7):894-901. PubMed ID: 17494640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model.
    Du L; Zhao G; He Y; Guo Y; Zheng BJ; Jiang S; Zhou Y
    Vaccine; 2007 Apr; 25(15):2832-8. PubMed ID: 17092615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies.
    Zhang H; Wang G; Li J; Nie Y; Shi X; Lian G; Wang W; Yin X; Zhao Y; Qu X; Ding M; Deng H
    J Virol; 2004 Jul; 78(13):6938-45. PubMed ID: 15194770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a eukaryotic expression plasmid encoding partial S gene fragments of the SARS-CoV and its potential utility as a DNA vaccine.
    He H; Tang Y; Qin X; Xu W; Wang Y; Liu X; Liu X; Xiong S; Li J; Zhang M; Duan M
    DNA Cell Biol; 2005 Aug; 24(8):516-20. PubMed ID: 16101350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Potent neutralization antibody elicited in mice by SARS-associated coronavirus spike protein S1 domain].
    Zhang Y; Yang F; Li YH; Li WH; Tu XM; Wei Q; Zhu H; Liu L; Wang H; Qin C; Yuan GY; He W; Wang SH
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):258-60. PubMed ID: 15640862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies.
    Zhou T; Wang H; Luo D; Rowe T; Wang Z; Hogan RJ; Qiu S; Bunzel RJ; Huang G; Mishra V; Voss TG; Kimberly R; Luo M
    J Virol; 2004 Jul; 78(13):7217-26. PubMed ID: 15194798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of cytotoxic T-lymphocyte epitopes and immune responses to SARS coronavirus spike DNA vaccine expressing the RGD-integrin-binding motif.
    Poh WP; Narasaraju T; Pereira NA; Zhong F; Phoon MC; Macary PA; Wong SH; Lu J; Koh DR; Chow VT
    J Med Virol; 2009 Jul; 81(7):1131-9. PubMed ID: 19475608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization of mice with a DNA vaccine based on severe acute respiratory syndrome coronavirus spike protein fragment 1.
    Zhao B; Jin NY; Wang RL; Zhang LS; Zhang YJ
    Viral Immunol; 2006; 19(3):518-24. PubMed ID: 16987069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and protection efficacy of monomeric and trimeric recombinant SARS coronavirus spike protein subunit vaccine candidates.
    Li J; Ulitzky L; Silberstein E; Taylor DR; Viscidi R
    Viral Immunol; 2013 Apr; 26(2):126-32. PubMed ID: 23573979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunity induced by recombinant spike proteins of SARS coronavirus in Balb/c mice.
    Qin L; Wang X; Wu S; Yuan S; Huang D; Lei M; Pan H; Lin Q
    J Huazhong Univ Sci Technolog Med Sci; 2007 Jun; 27(3):221-4. PubMed ID: 17641827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calreticulin as a hydrophilic chimeric molecular adjuvant enhances IgG responses to the spike protein of severe acute respiratory syndrome coronavirus.
    Qiu X; Hong C; Li Y; Bao W; Gao XM
    Microbiol Immunol; 2012 Aug; 56(8):554-61. PubMed ID: 22530918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative comparison of the efficiency of antibodies against S1 and S2 subunit of SARS coronavirus spike protein in virus neutralization and blocking of receptor binding: implications for the functional roles of S2 subunit.
    Zeng F; Hon CC; Yip CW; Law KM; Yeung YS; Chan KH; Malik Peiris JS; Leung FC
    FEBS Lett; 2006 Oct; 580(24):5612-20. PubMed ID: 16989815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design.
    He Y; Li J; Heck S; Lustigman S; Jiang S
    J Virol; 2006 Jun; 80(12):5757-67. PubMed ID: 16731915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.
    Liu YV; Massare MJ; Barnard DL; Kort T; Nathan M; Wang L; Smith G
    Vaccine; 2011 Sep; 29(38):6606-13. PubMed ID: 21762752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.